SUMMARY
We compared saturations from a paediatric central venous oximetry catheter with co-oximetry values with changes in drug infusions, intravascular blood volume and hypoxia in an animal model. Piglets (large white) were anaesthetised, intubated and mechanically ventilated. PediaSat ® oximetry catheters were placed in the superior vena cava via jugular vein cut-down and in the inferior vena cava percutaneously via the femoral vein. A carotid arterial catheter was placed via cut-down for blood sampling and pressure monitoring. Anaesthesia was maintained with continuous thiopentone and supplemental morphine. Haemodynamics (heart rate, mean arterial blood, central venous pressure), fibreoptic ScvO 2 (ScvO 2 -inferior) from inferior vena cava, fibreoptic ScvO 2 (ScvO 2 -superior) from superior vena cava and blood gas oximetry (ScvO 2 -co-ox) were measured simultaneously at predetermined intervals during increasing adrenaline and sodium nitroprusside infusions and during increasing hypoxia and hypovolaemia. There was good agreement of both superior vena cava and inferior vena cava ScvO 2 catheters with co-oximetry during adrenaline and sodium nitroprusside infusions. During the hypoxia study there was good agreement between the co-oximeter to ScvO 2 -superior catheter, but poor agreement with to the inferior vena cava catheter samples. In the hypovolaemic phase of the experiment there was good agreement between the measured co-oximetry value and ScvO 2 -superior catheter until the mean blood pressure reached 43 mmHg. The oximetry catheter is capable of identifying changes in ScvO 2 under physiological conditions usually encountered in clinical medicine but was less accurate at the extremes of physiology and when placed in the inferior vena cava catheter especially during hypovolaemia and hypoxia.
Key Words: critical illness, monitoring, haemodynamic monitoring, central venous saturation, animals Anaesth Intensive Care 2010; 38: [883] [884] [885] [886] [887] [888] [889] Oxygen consumption and delivery are important considerations in the management of critically ill children 1, 2 . Ensuring optimal delivery of oxygen is especially important in infants and neonates in whom hypoxaemia may occur with little warning and result in significant morbidity 3, 4 . Traditional methods of monitoring such as clinical assessment and laboratory predictors of poor tissue perfusion such as blood lactate may be late signs 5, 6 .
Anaesthesia and Intensive Care, Vol. 38, No. 5, September 2010 infusions that may alter vessel calibre; conditions under which the catheters are likely to be used in the critically ill neonate and child 18, 20, 21 .
With this in mind, we designed a study to evaluate the effects of clinically relevant changes in drug infusions, intravascular volume depletion with hypotension and hypoxia on the readings from the PediaSat Oximetry Catheter placed in the superior vena cava (SVC) and inferior vena cava (IVC) and to compare those values to co-oximetry values from simultaneously obtained blood samples drawn from the catheters.
MATERIALS AND METHODS
The experimental protocol was approved and monitored by the University of British Columbia's research committee on animal care.
Five piglets (6.3±1.1 kg) aged 3.2±0.4 weeks were premedicated with atropine (20 µg/kg), ketamine (20 mg/kg) and midazolam (200 µg/kg) intramuscularly. Anaesthesia was induced with isoflurane 1 to 4% via mask with supplemental oxygen. Once the animals were deeply anaesthetised they were orally intubated. Ventilation was commenced using an Ohmeda Modulus II anaesthesia machine (Datex-Ohmeda, Helsinki, Finland) breathing a mixture of isoflurane 1 to 2% and 60% oxygen.
A transverse neck incision was made following infiltration of the skin with 1% lignocaine (with adrenaline) to obtain access to the internal and external jugular veins and carotid arteries. The right internal jugular vein was cannulated with a 4.5 French 5 cm double-lumen PediaSat Oximetry Catheter positioned in the SVC. Correct positioning was confirmed by the appearance of the appropriate transduced waveform on the monitor. The right carotid artery was cannulated with a 2.5 French 2.5 cm single-lumen cannula (Cook Inc., Bloomington, IN, USA) to provide arterial access for continuous blood pressure monitoring and blood sampling. The right femoral vein was percutaneously cannulated with a 4.5 French 5 cm double-lumen Pediasat Oximetry Catheter positioned in the abdomen. Both ScvO 2 catheters were connected to optical modules coming from the monitoring platform (Vigileo™ Monitor, Edwards Life Sciences). In vivo calibration was performed as per Edwards Life Sciences protocol. A single-point calibration is performed by adjusting for haemoglobin and oxygen saturation values (ScvO 2 -co-ox) as measured by venous blood gas co-oximetry (Radiometer ® OSM3, Nutley, NJ, USA) withdrawn from the distal lumen of the catheter. Accuracy of the catheter in a laboratory setting is ±2% coefficient of variability in a range of 30 to 99% oxygen saturations. Electrocardiogram, pulse oximetry (SpO 2 ), mean systemic arterial pressure, central venous pressure, end-tidal carbon dioxide (ETCO 2 ) and temperature were continuously monitored throughout the experiment using the Hewlett-Packard Merlin monitor. An orogastric tube was inserted and allowed to drain freely. Normothermia (37.5°C) was maintained with a warming blanket and overhead infrared lamps.
After the cannulation procedures were completed, the isoflurane was discontinued and anaesthesia maintained for the remainder of the experiment using a combination of continuous infusions of thiopentone (5 mg/kg/hour) supplemented with continuous intravenous morphine (10 to 40 µg/kg/hour). The animals were continuously observed for clinical signs of inadequate depth of anaesthesia by observing for signs of movement and respiratory effort. Due to the effects of the protocols on tachycardia and hypertension these variables were monitored between the various protocols and change in values above baseline were used as an indicator of depth of anaesthesia. Muscle paralysis was used only during the hypoxia protocol. Paralysis was achieved through intermittent boluses of pancuronium (200 µg/kg). Normal ventilation parameters established were tidal volume (Vt ~10 ml/kg), respiratory rate 18 breaths per minute and minimum inspired oxygen (FiO 2 ) to maintain SpO 2 >98%. Arterial blood gas measurements of pH, P a O 2 , P a CO 2 and HCO 3 were done at baseline for each change using the Abbott ® i-Stat point-of-care testing device.
At the completion of the experiment, the animals were euthanised using concentrated sodium pentobarbitol (240 mg/ml) dosed at 1 ml per 4.5 kg of body weight.
Experimental protocols
There were three separate protocols for the following: 1) drug infusions (adrenaline and sodium nitroprusside); 2) ventilation with hypoxic gas mixture and 3) exsanguination to achieve hypovolaemia. The animals were stabilised between each protocol until their vitals signs returned to baseline values. The catheters were re-calibrated at the start of each protocol. The protocols were administered in the same order for each animal starting with the drug infusions and ending with hypovolaemia. All blood samples for co-oximetry were drawn from the distal lumen of the catheter. Based on a lumen volume of 0.2 ml, 1 ml of blood was discarded prior to the sample being drawn. Each sample was placed on ice and analysed within five minutes.
Drug infusions
Following instrumentation and stabilisation, adrenaline was started at 0.1 µg/kg/minute and increased in increments of 0.1 µg/kg/minute at 10 minute intervals until a rate of 0.4 µg/kg/minute was reached. The infusion was weaned to off at similar increments. Vital signs were allowed to return to baseline at the end of the adrenaline infusion over 10 to 15 minutes prior to starting sodium nitroprusside. Sodium nitroprusside was given by continuous infusion starting at 0.1 µg/kg/minute and increased every 10 minutes to a maximum of 0.6 µg/kg/minute as per protocol then weaned in similar increments. Readings from the ScvO 2superior and ScvO 2 -inferior catheters as well as simultaneously obtained blood for ScvO 2 -co-ox measurement from the distal lumen of each catheter were obtained at baseline and with each increment and decrement.
Ventilation with hypoxic gas
Following ventilation to normal pH, P a O 2 and P a CO 2 values, the FiO 2 was then decreased by 2% decrements every five minutes until a ScvO 2 -co-ox value of 30% was reached as measured by cooximetry from the distal lumen of the SVC catheter. Based on the protocol of using the minimum inspired oxygen to obtain saturation >98%, the starting point of the inspired oxygen varied for each animal (range 0.21 to 0.24) which resulted in a range (0.13 to 0.16) of minimum inspired oxygen to obtain the goal of ScvO 2 -co-ox value of 30%. Readings from the ScvO 2 -superior and ScvO 2 -inferior catheters as well as corresponding ScvO 2 -co-ox measurement from blood sampled from the distal lumen of each catheter were obtained at baseline and with each decrement of FiO 2 . The animal was then reoxygenated until the SpO 2 was greater than 95%.
Hypovolaemia
The animals were bled in 15 ml/kg aliquots over five minutes at 15 minute intervals to a mean blood pressure of 20 mmHg using 60 ml syringes with 500 units of heparin added to prevent coagulation. The blood was then re-infused in 15 ml/kg aliquots over 10 minutes for each aliquot. Readings from the ScvO 2 -superior and ScvO 2 -inferior catheters as well as the corresponding ScvO 2 -co-ox measurement from blood sampled from the distal lumen of each catheter were obtained at baseline and with each 15 ml/kg aliquot adjustment in blood volume.
After the blood was re-infused, a normal saline infusion was started at a rate of 50 ml/hour through the proximal lumen of the catheter to assess the effect of flow rate of an isotonic solution on the ScvO 2 reading in the SCV in regard to possible dilution at the catheter tip. The flow rate was doubled every minute until the maximum flow rate capable by the intravenous pump (999 ml/hour) was reached while observing for changes on the corresponding ScvO 2 -superior and ScvO 2 -inferior monitors.
Statistical analysis
Results are expressed as mean ± standard deviation. Co-oximetry values and ScvO 2 catheter readings were compared using Bland-Altman analyses for agreement between co-oximetry and catheter readings.
RESULTS
In all animals, haemodynamic changes were achieved by incremental doses of continuous adrenaline. The maximal dose of adrenaline (0.4 µg/kg/minute) resulted in an increase in the mean blood pressure of 24% and heart rate of 36%. A continuous sodium nitroprusside infusion to a maximum of 0.6 µg/kg/minute resulted in a maximum decrease in the mean blood pressure of 24%. Decreasing inspired oxygen in 2% steps until a ScvO 2 -superior of 30% was achieved resulted in a decrease in SpO 2 of 53%. Incremental blood draws resulted in decline in mean systemic arterial pressure of 67%.
There was good agreement between the cooximetry and ScvO 2 -superior catheter values in the adrenaline infusion protocol at all infusion levels (Bland-Altman bias -1.7, SD±3.8) ( Figure 1) . Similar results were observed between co-oximetry to ScvO 2 -inferior catheter values (Bland-Altman bias 0.8, SD±4.6) ( Figure 2 ). There was good agreement between the co-oximetry and ScvO 2 -superior in the sodium nitroprusside infusion protocol (Bland-Altman bias -0.2 SD±4.6) ( Figure 3 ). The agreement was good between the co-oximetry and ScvO 2 -inferior (Bland-Altman bias -0.4, SD±6.9) (Figure 4 ).
During the hypoxia study there was good agreement between the co-oximeter to ScvO 2 -superior catheter (Bland-Altman bias -2.4, SD±7.0) ( Figure 5 ). Comparison of the co-oximeter with the ScvO 2 -inferior showed poor agreement with a large negative bias (Bland-Altman bias -5.3, SD±11.2) ( Figure 6 ).
In the hypovolaemic phase of the experiment there was good agreement between the measured co-oximetry value and ScvO 2 -superior catheter until the mean blood pressure reached 43 mmHg (Bland-Altman bias -2.8, SD±6.0). However, including values less than 43 mmHg resulted in poor agreement (Bland-Altman bias -8.8, SD±18.4) ( Figure 7) . The analysis of the data for the co-ox to ScvO 2 -inferior catheter showed poor agreement with a large negative bias (Bland-Altman bias -11.9, SD±22.0) (Figure 8) .
The results of increasing the infusion rate of normal saline through the proximal lumen of the catheter in the SVC up to the pump's maximum rate of 999 ml/hour over six minutes did not change the ScvO 2 -superior reading.
DISCUSSION
We conducted this study to test the limits of the catheter under a range of conditions that simulate the physiology seen in some paediatric patients requiring intensive care. By using animals we were able to produce extremes of physiology that have not been described in previous papers evaluating the PediaSat ® catheter. We found the catheter placed in the SVC demonstrated consistently better agreement between co-oximetry and catheter values than that of the catheter in the IVC. We also found that the accuracy of the SVC catheter is acceptable during hypoxia whereas the IVC catheter resulted in large negative bias with limits of agreement that would be clinically unacceptable. During hypovolaemia both the SVC and IVC data demonstrated large biases and very wide limits of agreement that would make clinical utility questionable, however the SVC catheter agreement was good until the mean arterial blood pressure was reduced below 43 mmHg. This data is important because while the usefulness of this catheter is its ability to detect subtle changes not identified by other common clinical vital signs such as heart rate, blood pressure and pulse oximetry, it is equally important to know its limits when physiology is markedly deranged.
There are many factors that can influence the ability of the catheter to accurately reflect the saturation of the blood flowing through the vessel where the catheter sits. The catheter functions by emission of infrared light through a fibreoptic cable which is then reflected or absorbed; the reflected infrared light is received by a second fibreoptic cable imbedded in the wall of the catheter. If there is any interference to the emission or reception of the infrared light, the accuracy of the catheter will be affected. Examples of this type of interference include the catheter tip against a vessel wall, clot or fibrin on the tip of the catheter occluding one or both of the fibreoptic cables and a decrease in the diameter of the vessel wall. A small decrease in vessel calibre is more likely to affect readings in infants and neonates in whom the vessel lumen is already small. This may explain why the IVC catheter is less reliable in that hypoxia and hypotension may result in redistribution of blood flow to the vital organs at the expense of the lower torso and abdomen.
We found that while the signal quality displayed by the Vigileo monitor indicated poor signal quality at times when the results were clinically different, the reverse was also true where the monitor indicated a good signal with results that did not clinically agree. Another factor to explain the variance in readings at extremes from baseline is the fact that calibration of the catheter at a single point along the saturation spectrum produces a calibration curve 22 . This calibration curve will only be accurate within a given range surrounding that value. As the actual value moves farther away from the calibration value the accuracy will diminish. Changes in haemoglobin level and haematocrit are also known to affect the accuracy of the catheter and the manufacturer recommends updating the calibration if the haemoglobin changes by more than 18 g/l or the haematocrit changes by more than 6% from the value at the time of calibration. The haemoglobin value was updated as part of the calibration procedure at the start of each protocol and did not vary by greater than 14 g/l prior to recalibration. The hypovolaemia protocol involved removal of aliquots of whole blood and as such the haemoglobin value remained within the 18 g/l range of the baseline value.
An advantage of using this catheter versus pointin-time measurements in the critical care setting is the ability to identify changes in ScvO 2 values that might be present prior to changes in other commonly monitored physiologic values which indicate a change in the oxygen delivery/consumption equation 23 . To date, we have not identified any publications that have described the performance of the catheter where large changes in commonly monitored physiologic values and possible subsequent changes in the oxygen/delivery consumption equation have occurred. The results of this study indicate that the catheter is capable of identifying changes in ScvO 2 through a wide range of physiology. However, in situations where there are changes in physiologic parameters such as blood pressure, arterial saturations and intravascular volume in excess of 20% from the baseline at which the catheter was calibrated, we recommend that the catheter be recalibrated. In addition, if at all possible the preferred site of the catheter should be the SVC rather than the IVC.
There are a few limitations to our study. Small sample size precludes us making any categorical statements as to the physiological limits of the catheter's accuracy. Moreover, these were healthy animals and the response to drugs, hypovolaemia and hypoxia may be different in a sick infant or child. Also, we did not evaluate whether recalibration of the catheter would make any difference when there were significant variation between the cooximetry results and the catheter results associated with large changes in the physiologic status of the animal. Recalibration may reduce these differences as outlined above. In addition, we did not evaluate whether these changes were reflected in changes in systemic perfusion, pulmonary artery saturation or cardiac output.
CONCLUSION
In summary, we found that the catheter is capable of identifying changes in ScvO 2 through physiologic changes usually encountered in clinical medicine but were less accurate at the extremes of physiology. The SVC catheter consistently demonstrated better agreement and correlation compared to co-oximetry values under all conditions than the IVC catheter. Whenever possible a catheter in the SVC should be used.
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